Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test — Stella

Recruiting

Back to Prostate Cancer trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

United States

University of Chicago Medical Center, Chicago, Illinois

Albany Medical Center, Albany, New York

Penn State-Hershey Medical Center, Hershey, Pennsylvania

Key details

Phase

Post-approval study

Sponsor

Albany Medical College

Enrollment target

~198 participants

Started

September 2022

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Sex

Male only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov